"We are going to have lung cancer patients living longer and better:" A new kind of cancer treatment is about to change how we treat the disease (MRK, BMS)

Wikimedia Commons New cancer treatments that harness the body's immune system are ready to go mainstream.  In data presente.....»»

Category: topSource: businessinsiderApr 16th, 2018

AstraZeneca"s Tagrisso Wins EU Nod for First-Line Lung Cancer

AstraZeneca's (AZN) Tagrisso gets an EU nod for first-line treatment of advanced or metastatic non-small cell lung cancer in patients with epidermal growth factor receptor (EGFR) m.....»»

Category: personnelSource: nytJun 11th, 2018

Study finds rare gain for tough-to-treat pancreatic cancer

Patients with pancreatic cancer that hadn't spread lived substantially longer on .....»»

Category: topSource: foxnewsJun 4th, 2018

A cancer treatment that one expert called the "most exciting thing I"ve seen in my lifetime" just got approved to treat more patients (NVS, GILD)

Reuters The FDA just approved a cutting-edge .....»»

Category: topSource: businessinsiderMay 2nd, 2018

Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer

A combination of Merck's Keytruda and chemotherapy cut lung cancer death rates in half. New study results released Monday continue to cemen.....»»

Category: europeSource: fortuneApr 16th, 2018

Merck"s Keytruda helps lung cancer patients live longer in trial

(Reuters) - Merck & Co's blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing its position as the dominant player in the lucrative lung cancer market......»»

Category: topSource: reutersApr 9th, 2018

Merck"s Keytruda meets main goal in pivotal lung cancer trial

(Reuters) - Merck & Co said on Monday a late-stage trial of its blockbuster cancer drug Keytruda met the main goal in helping previously untreated lung cancer patients live longer, sending its shares up 2.6 percent in premarket trade......»»

Category: topSource: reutersApr 9th, 2018

Merck"s Keytruda Gets Priority Review in Difficult Lung Cancer

Merck's (MRK) sBLA looking to expand the label of Keytruda for first-line treatment of metastatic squamous NSCLC gets FDA's priority review. The decisio.....»»

Category: worldSource: nytJul 3rd, 2018

Merck"s (MRK) Keytruda Gets FDA Approval for Cervical Cancer

Merck's (MRK) Keytruda receives accelerated approval for the treatment of patients with advanced cervical cancer. Merck MRK has received FDA’s accelerated approval for label.....»»

Category: smallbizSource: nytJun 13th, 2018

A study of more than 10,000 breast cancer patients found that some can skip chemotherapy without hurting their chances of beating the disease

Thomson Reuters A study found that around 70,000 early-stage breast cancer patients a year could safely skip chemotherapy without hurting their chances of beating the disease. The study used a genetic te.....»»

Category: topSource: businessinsiderJun 4th, 2018

The Wall Street Journal: Cancer researchers suggest ‘less is more’ approach to treatment

Cancer researchers are increasingly exploring whether they can eliminate or scale back treatments to spare patients from tough side effects — and costs — without jeopardizing survival......»»

Category: topSource: marketwatchJun 3rd, 2018

Many breast cancer patients can skip chemo, big study finds

Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk......»»

Category: topSource: foxnewsJun 3rd, 2018

AstraZeneca"s drug extending survival rate in lung cancer patients

Using Imfinzi in stage III lung cancer, where cancer has only spread locally, opens up a multibillion-dollar sales opportunity.....»»

Category: topSource: business-standardMay 26th, 2018

Florida Supreme Court issues order in Joe Redner"s battle for homegrown marijuana

The Florida Supreme Court has refused to give emergency relief to Tampa strip clude owner Joseph Redner in his attempt to lift an appeals court order blocking him from growing his own medical marijuana to treat his late stage lung cancer. The stat.....»»

Category: topSource: bizjournalsMay 25th, 2018

NuCana Reports First Quarter 2018 Financial Results

EDINBURGH, United Kingdom, May 23, 2018 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients, announced financial resul.....»»

Category: earningsSource: benzingaMay 23rd, 2018

Soothe to give free massages to cancer patients

Soothe is setting up its massage chairs and tables at the City of Hope Medical Center. The Los Angeles on-demand massage startup has partnered with the Southern California cancer treatment and research center to provide free massages to patients, .....»»

Category: topSource: bizjournalsMay 23rd, 2018

Apollo Hospitals joins hands with IBM Watson for cancer treatment

These platforms will help physicians provide patients with personalised, evidence-based cancer care.....»»

Category: dealsSource: nytMay 22nd, 2018

Shorter drug treatment OK for many breast cancer patients

Many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12, greatly reducing the risk of heart damage it sometimes can cause, a study suggests......»»

Category: topSource: foxnewsMay 16th, 2018

Kanpur, the world"s most polluted city, struggles to contain disease

Problems from air pollution are leading to multiple diseases such as lung cancer, bronchial asthma, chronic obstructive pulmonary disease and pneumonia.....»»

Category: topSource: business-standardMay 15th, 2018

All Cancer Patients Should Be Prescribed Exercise, Oncology Organization Recommends

Exercise is like a pill that greatly reduces side effects from cancer treatment......»»

Category: topSource: newsweekMay 7th, 2018

A cutting-edge new cancer treatment has two different price tags — and it could be the future of how we pay for drugs

AP A cutting-edge new cancer treatment from Novartis called Kymriah just got approved to treat more people with certain blood cancers la.....»»

Category: topSource: businessinsiderMay 7th, 2018